Acro Biomedical reported total assets of $0.00M and total liabilities of $0.45M for the quarter ended Jun 2026, down 85.5% year over year. This balance sheet covers 43 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.22M | 0.15M | 0.10M | 0.36M | 0.01M | 0.02M | 0.01M | 322.00 | 0.00M | 0.00M | 376.00 | 151.00 | 926.00 | 701.00 | 476.00 | 251.00 | 26.00 | 0.00M | 0.00M | 0.00M | |||||||||||||||||||||||
| Cash & Current Investments | 0.22M | 0.15M | 0.10M | 0.36M | 0.01M | 0.02M | 0.01M | 322.00 | 0.00M | 0.00M | 376.00 | 151.00 | 926.00 | 701.00 | 476.00 | 251.00 | 26.00 | 0.00M | 0.00M | 0.00M | |||||||||||||||||||||||
| Receivables - NetNet Receivables | 0.60M | 0.30M | 0.30M | 0.28M | 0.64M | 0.61M | 0.50M | ||||||||||||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | |||||||||||||||||||||||||||||||||||||||||||
| Receivables | 0.60M | 0.30M | 0.30M | 0.28M | 0.64M | 0.61M | 0.50M | ||||||||||||||||||||||||||||||||||||
| Inventory | 0.45M | 0.45M | 0.30M | 0.30M | |||||||||||||||||||||||||||||||||||||||
| Prepaid Assets | 0.01M | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.00M | 0.04M | 0.01M | ||||||||||||||||||||||||||||||
| Current Assets | 0.69M | 0.62M | 0.71M | 0.68M | 0.63M | 0.61M | 0.66M | 0.64M | 0.53M | 0.01M | 0.00M | 151.00 | 926.00 | 701.00 | 0.01M | 0.00M | 0.04M | 0.00M | 0.01M | 0.00M | |||||||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||||||||||||
| Long-Term Deferred Tax | |||||||||||||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||||||||||||||||||||||||||
| Non-Current Assets | 0.01M | 0.01M | 0.05M | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M | 0.01M | 0.01M | 0.06M | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M | 0.01M | ||||||||||||||||||||||||||
| Assets | 0.70M | 0.63M | 0.76M | 0.73M | 0.67M | 0.64M | 0.69M | 0.66M | 0.54M | 0.02M | 0.06M | 0.05M | 0.05M | 0.04M | 0.03M | 0.03M | 0.05M | 0.00M | 0.01M | 0.00M | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||||||||||||
| Accounts Payables | 0.01M | 0.02M | 0.03M | 0.01M | 0.02M | 0.08M | 0.13M | 0.09M | 0.15M | 0.15M | 0.15M | 0.15M | 0.16M | 0.15M | 0.14M | 0.10M | 0.12M | 0.06M | 0.06M | ||||||||||||||||||||||||
| Payables | 0.01M | 0.02M | 0.03M | 0.01M | 0.02M | 0.08M | 0.13M | 0.09M | 0.15M | 0.15M | 0.15M | 0.15M | 0.16M | 0.15M | 0.14M | 0.10M | 0.12M | 0.06M | 0.06M | ||||||||||||||||||||||||
| Other Accumulated Expenses | 0.08M | 0.08M | 0.08M | 0.09M | 0.00M | 0.00M | 0.00M | ||||||||||||||||||||||||||||||||||||
| Current Taxes | |||||||||||||||||||||||||||||||||||||||||||
| Current Deferred Revenue | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | |||||||||||||||||||||||||||
| Total Current Liabilities | 0.06M | 0.06M | 0.09M | 0.07M | 0.08M | 0.14M | 0.20M | 0.25M | 0.20M | 0.26M | 0.29M | 0.30M | 0.31M | 0.32M | 0.33M | 0.33M | 0.37M | 0.44M | 0.40M | 0.45M | |||||||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||||||||||||
| Operating Leases | 0.01M | 0.03M | 0.02M | 0.01M | 0.01M | 0.03M | 0.02M | 0.01M | 0.01M | ||||||||||||||||||||||||||||||||||
| Total Liabilities | 0.06M | 0.06M | 0.12M | 0.09M | 0.09M | 0.15M | 0.20M | 0.25M | 0.20M | 0.26M | 0.32M | 0.32M | 0.32M | 0.32M | 0.33M | 0.33M | 0.37M | 0.44M | 0.40M | 0.45M | |||||||||||||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||||||||||||
| Common Equity | 0.64M | 0.57M | 0.64M | 0.64M | 0.57M | 0.49M | 0.49M | 0.41M | 0.34M | -0.24M | -0.26M | -0.27M | -0.28M | -0.29M | -0.29M | -0.30M | -0.32M | -0.43M | -0.39M | -0.44M | |||||||||||||||||||||||
| Liabilities and Shareholders Equity | 0.70M | 0.63M | 0.76M | 0.73M | 0.67M | 0.64M | 0.69M | 0.66M | 0.54M | 0.02M | 0.06M | 0.05M | 0.05M | 0.04M | 0.03M | 0.03M | 0.05M | 0.00M | 0.01M | 0.00M | |||||||||||||||||||||||
| Retained Earnings | -1.09M | -4.08M | -7.94M | -11.87M | -15.86M | -19.87M | -23.81M | -27.81M | -31.01M | -32.60M | -32.62M | -32.63M | -32.64M | -32.65M | -32.66M | -32.67M | -32.68M | -32.80M | -32.76M | -32.82M |
Pull Acro Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ACBM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ACBM", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=ACBM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();